Dublin, March 15, 2017 -- Research and Markets has announced the addition of the "Biosurgery: Technologies and Global Markets" report to their offering.
The Global Biosurgery Market Should Reach $12.5 Billion by 2021 from $8.3 Billion in 2016 at a CAGR of 8.5%
This report analyzes the market for products used to reduce excessive hemorrhage during surgery. In a surgical procedure, these products are used as adhesion agents to seal wounds and to repair damaged or weakened tissue.
Due to their ease of application, these products improve the work efficiency of surgeons. Biosurgery products can be used to disinfect wounds with the help of maggots, and are used particularly for chronic infected wounds, which do not get treated by antibiotics. This report covers all of the existing applications of biosurgery products.
The global biosurgery market is segmented primarily by product type, application, source, and region. Biosurgery products are segmented by type into anti-adhesive agents, hemostatic agents, surgical sealing agents, bone-graft substitutes, and soft-tissue management. The application segments include cardiothoracic surgery, neurosurgery and spine surgery, orthopedic surgery, and general surgery. Based on source, the biosurgery market is segmented into biological and synthetic products.
An in-depth analysis of these segments is given in this report. The report also provides a detailed qualitative account of the market dynamics, technology trends, key strategies, and regulatory scenario.
Report Includes:
- An overview of the global market for biosurgery.
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Segmentation of the market on the basis of product type, source, application, and region.
- In depth coverage of the market dynamics, technology trends, drivers, constraints, and key strategies.
- Discussion of government regulations, medical associations & international regulatory agencies.
- Analysis of patents pertaining to biosurgery.
- Profiles of companies related to the industry.
Key Topics Covered:
1: Introduction
- Study Objectives
- Scope Of Report
- Intended Audience
- Source Of Information And Methodology
2: Executive Summary
3: Market Overview
- Market Evolution And Innovation
- Government Regulations, Medical Associations, And International Regulatory Agencies
- Demographics, Incidence And Prevalence Rates, And Other Factors Influencing Biosurgery Market Growth
- Clinical Guidelines And Reimbursement Scenario
- Technology Trends
- Biosurgery Pipeline
- Novel Technologies For The Future Of Biosurgery
- Key Strategies
- Market Dynamics
4: Biosurgery Market By Product Type
- Anti-Adhesive Agents
- Hemostatic Agents
- Surgical Sealing Agents
- Bone-Graft Substitutes
- Soft-Tissue Management/Mesh/Patch
5: Biosurgery Market By Application
- Cardiothoracic Surgery
- Neurosurgery And Spine Surgery
- Orthopedic Surgery
- General Surgery
- Incidence Rates Of Surgical Procedures And Analysis
6: Biosurgery Market By Source
- Natural/Biological Products
- Synthetic Products
7: Competitive Landscape
- Product Development
- Agreement
- Acquisition
- Expansion
8: Biosurgery Market By Region
- North America
- Europe
- Asia-Pacific
- Rest Of World
9: Patent Analysis
- U.S. Patent Analysis
- Europe Patent Analysis
- Japan Patent Analysis
- China Patent Analysis
- Korea Patent Analysis
10: Company Profiles
- B. Braun Melsungen AG
- Baxter International Inc.
- Cerapedics Inc.
- Cohera Medical Inc.
- C.R. Bard Inc.
- Cryolife Inc.
- Exactech Inc.
- Hemostasis Llc
- Hyperbranch Medical Technology Inc.
- Johnson & Johnson
- Kuros Biosciences AG
- Medtronic Plc
- Rti Surgical
- Sanofi SA
- Smith & Nephew Plc
- Stryker Corp.
- Tissuemed Ltd.
- Wright Medical Group NV
- Z-Medica Corp.
- Zimmer Biomet Holdings Inc.
11: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/r95k3x/biosurgery
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Surgical Procedures


L3Harris Nears $500M Deal to Sell Majority Stake in Space Propulsion Portfolio to AE Industrial
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Samsung Electronics Hits Record High as AI Momentum Fuels Investor Optimism
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
U.S. Airline Flight Cancellations Surge After Venezuela Military Operation and FAA Airspace Closures
Grok AI Controversy on X Sparks Global Outrage Over Nonconsensual Images
Kia Targets 3.35 Million Global Vehicle Sales in 2026 Amid Steady Growth Outlook
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Reddit Emerges as a Major Winner in the Shift to AI-Powered Search 



